Isadore Brodsky, M.D., F.A.C.P.; Donald N. Gill, M.D.; Charles J. Lusch, M.D.
This content is PDF only. Please click on the PDF icon to access.
The existence of preoperative fibrinolysis and the response to treatment with epsilon aminocaproic acid (EACA) were studied in six patients with cyanotic or acyanotic congenital heart disease. The fibrinolytic mechanism and the third stage of coagulation were evaluated with  euglobulin clot lysis time,  serial thrombin time,  platelet count,  plasma fibrinogen, and  presence of split products of fibrinogen. The first and second stages of coagulation were studied with prothrombin time, partial thromboplastin time, and factor V assay. All six patients had primary fibrinolysis of varying degrees of severity and were treated preoperatively with EACA. This resulted
Learn more about subscription options.
Register Now for a free account.
Brodsky I, Gill DN, Lusch CJ. Fibrinolysis in Congenital Heart Disease: Preoperative Treatment with Epsilon Aminocaproic Acid.. Ann Intern Med. 1968;68:1165. doi: 10.7326/0003-4819-68-5-1165_2
Download citation file:
Published: Ann Intern Med. 1968;68(5):1165.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only